Cree BAC - Search Results

1

Secondary Progressive Multiple Sclerosis: New Insights.

Cree BAC, Arnold DL, Chataway J, Chitnis T, Fox RJ, Pozo Ramajo A, Murphy N, Lassmann H. Cree BAC, et al. Neurology. 2021 Aug 24;97(8):378-388. doi: 10.1212/WNL.0000000000012323. Epub 2021 Jun 4. Neurology. 2021. PMID: 34088878 Free PMC article. Review.

2

Neuromyelitis optica.

Cree BA, Goodin DS, Hauser SL. Cree BA, et al. Semin Neurol. 2002 Jun;22(2):105-22. doi: 10.1055/s-2002-36534. Semin Neurol. 2002. PMID: 12524556 Review.

3

Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis.

Barcellos LF, Begovich AB, Reynolds RL, Caillier SJ, Brassat D, Schmidt S, Grams SE, Walker K, Steiner LL, Cree BA, Stillman A, Lincoln RR, Pericak-Vance MA, Haines JL, Erlich HA, Hauser SL, Oksenberg JR. Barcellos LF, et al. Ann Neurol. 2004 Jun;55(6):793-800. doi: 10.1002/ana.20092. Ann Neurol. 2004. PMID: 15174013

4

Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis.

Cree BA, Khan O, Bourdette D, Goodin DS, Cohen JA, Marrie RA, Glidden D, Weinstock-Guttman B, Reich D, Patterson N, Haines JL, Pericak-Vance M, DeLoa C, Oksenberg JR, Hauser SL. Cree BA, et al. Neurology. 2004 Dec 14;63(11):2039-45. doi: 10.1212/01.wnl.0000145762.60562.5d. Neurology. 2004. PMID: 15596747

5

An open label study of the effects of rituximab in neuromyelitis optica.

Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C. Cree BA, et al. Neurology. 2005 Apr 12;64(7):1270-2. doi: 10.1212/01.WNL.0000159399.81861.D5. Neurology. 2005. PMID: 15824362 Clinical Trial.

6

Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis.

Menge T, Lalive PH, von Büdingen HC, Cree B, Hauser SL, Genain CP. Menge T, et al. J Allergy Clin Immunol. 2005 Aug;116(2):453-9. doi: 10.1016/j.jaci.2005.03.023. J Allergy Clin Immunol. 2005. PMID: 16083805

7

Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions.

Frohman EM, Filippi M, Stuve O, Waxman SG, Corboy J, Phillips JT, Lucchinetti C, Wilken J, Karandikar N, Hemmer B, Monson N, De Keyser J, Hartung H, Steinman L, Oksenberg JR, Cree BA, Hauser S, Racke MK. Frohman EM, et al. Arch Neurol. 2005 Sep;62(9):1345-56. doi: 10.1001/archneur.62.9.1345. Arch Neurol. 2005. PMID: 16157741 Review.

8

Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations.

Frohman EM, Stüve O, Havrdova E, Corboy J, Achiron A, Zivadinov R, Sorensen PS, Phillips JT, Weinshenker B, Hawker K, Hartung HP, Steinman L, Zamvil S, Cree BA, Hauser S, Weiner H, Racke MK, Filippi M. Frohman EM, et al. Arch Neurol. 2005 Oct;62(10):1519-30. doi: 10.1001/archneur.62.10.1519. Arch Neurol. 2005. PMID: 16216934 Review.

9

Response to interferon beta-1a treatment in African American multiple sclerosis patients.

Cree BA, Al-Sabbagh A, Bennett R, Goodin D. Cree BA, et al. Arch Neurol. 2005 Nov;62(11):1681-3. doi: 10.1001/archneur.62.11.1681. Arch Neurol. 2005. PMID: 16286540

10

Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays.

Lalive PH, Menge T, Barman I, Cree BA, Genain CP. Lalive PH, et al. Neurology. 2006 Jul 11;67(1):176-7. doi: 10.1212/01.wnl.0000223346.09426.34. Neurology. 2006. PMID: 16832107 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page